Cargando…
A Case of Acquired Factor V Inhibitor Following Nivolumab Administration
Acquired factor V inhibitor (AFVI) is a very rare disease. We presented herein a case of hypopharyngeal cancer in which AFVI developed after nivolumab administration. Blood test findings two weeks after the first dose of nivolumab showed a significant prolongation of prothrombin time (PT) and activa...
Autores principales: | Kida, Wataru, Nakaya, Muneo, Ito, Akiko, Kozai, Yasuji, Bingo, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884452/ https://www.ncbi.nlm.nih.gov/pubmed/35242461 http://dx.doi.org/10.7759/cureus.21670 |
Ejemplares similares
-
Secondary Acquired Cholesteatoma in Langerhans Cell Histiocytosis Patient
por: Alhelali, Shaden, et al.
Publicado: (2022) -
A Case of Traumatic Cerebrospinal Fluid Rhinorrhea Successfully Treated Using Intravenous Factor XIII Administration
por: Yasuda, Iori, et al.
Publicado: (2021) -
A Case of Mumps Presenting With Unilateral Submandibular Sialadenitis and Laryngeal Edema
por: Ogawa, Go, et al.
Publicado: (2022) -
Diagnosis and Management of a Massive Eight-Centimeter Acquired Tracheoesophageal Fistula
por: Engel-Rodriguez, Andrew, et al.
Publicado: (2023) -
Impact of Neoadjuvant Chemotherapy on the Administration of Concurrent Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma
por: Maas, Benjamin, et al.
Publicado: (2018)